MARC Record from marc_columbia

LEADER: 05757cam a2200373Ia 4500
001 4187656
005 20221027052123.0
008 031021t20042004paua 000 0 eng d
010 $a 2003107485
020 $a1560535784
035 $a(OCoLC)ocm53288602
035 $a(NNC)4187656
035 $a4187656
040 $aH9C$cH9C$dNNC-M$dOrLoB-B
090 $aRC685.H8$bE436 2004
100 1 $aEgan, Brent M.$0http://id.loc.gov/authorities/names/n2003130594
245 10 $aHypertension /$cBrent M. Egan, Jan N. Basile, Daniel T. Lackland.
260 $aPhiladelphia, Penn. :$bHanley & Belfus,$c[2004], ©2004.
300 $axxi, 487 pages :$billustrations ;$c22 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aHot topics
504 $aIncludes bibliographical references and index.
505 00 $gSect. I.$tGeneral Evaluation of the Hypertensive Patient -- $g1.$tInitial Evaluation of Blood Pressure /$rJohn Kevin Hix and Donald G. Vidt -- $g2.$tThe Use of Home Blood Pressure Monitors in Practice /$rSteven A. Yarrows -- $g3.$tUrine Microalbumin: For Diabetics Only? /$rSunita Sharma and Eddie L. Greene -- $gSect. II.$tTarget Organ Evaluation in the Hypertensive Patient -- $g4.$tEvaluation of Cardiac Structure and Function /$rAlan Hinderliter -- $g5.$tAssessment of Renal Function in Hypertension /$rMeryl Waldman and Raymond R. Townsend -- $g6.$tRenal Artery Occlusive Disease in Hypertension /$rJames C. Stanley -- $g7.$tCarotid and Peripheral Vascular Disease /$rRobert D. Brook, Henna Kalsi and Alan B. Weder -- $gSect. III.$tScreening and Diagnosis of Selected Secondary Causes of Hypertension -- $g8.$tSleep Apnea: The Not So Silent Epidemic /$rNarayana S. Murali, Anna Svatikova and Virend K. Somers -- $g9.$tPrimary Aldosteronism /$rMarion Wofford -- $gSect. IV.$tManagement of Hypertension: Goals and Objectives -- $g10.$tTreating to Goal Blood Pressure /$rWilliam J. Elliot -- $g11.$tHigh Normal Blood Pressure /$rStevo Julius -- $g12.$tPatient-related Barriers to Hypertension Control /$rMiyong Kim, Martha Hill and Hwayum Lee -- $g13.$tHypertension Control: Focus on Providers /$rDavid Hyman -- $g14.$tCulturally Congruent Medical Care /$rB. Waine Kong and Stephanie Kong -- $gSect. V.$tLifestyle Approaches: Translating Research into Practice! -- $g15.$tPromoting Lifestyle Modification in the Office Setting /$rLawrence J. Appel and Edgar R. Miller -- $g16.$tDietary Cations and Hypertension /$rPaul K. Muntner, Paul K. Whelton and Jiang He -- $g17.$tNutrition, Dietary Supplements, and Nutraceuticals in Hypertension /$rMark C. Houston -- $g18.$tComorbid Depression and Hypertension-related Chronic Medical Conditions /$rLeonard E. Egede -- $g19.$tManagement of Obesity /$rPatrick Mahlen O'Neil and Corby K. Martin -- $g20.$tPhysical Activity for Patients with Hypertension /$rNancy S. Diehl and Kelly R. Evenson -- $g21.$tBehavioral Approaches in Blood Pressure Reduction /$rThomas Pickering -- $gSect. VI.$tMedical Therapy: Evidence-Based Approach to the Important Practical Issues -- $g22.$tAn Evidence-based Approach to Selecting Initial Antihypertensive Therapy /$rJan Basile -- $g23.$tRemedies for Single-Dose Therapy-Failure /$rBarry J. Materson -- $g24.$tThe Metabolic Syndrome /$rWilliam H. Bestermann, Jr. -- $g25.$tManaging Hypertension in Diabetic Patients /$rPeter D. Hart and George L. Bakris -- $g26.$tIsolated Systolic Hypertension /$rStanley S. Franklin -- $g27.$tManagement of Refractory Hypertension /$rLawrence R. Krakoff -- $gSect. VI.$tMedical Therapy: Meeting Most Management Challenges -- $g28.$tHypertension and Congestive Heart Failure /$rAlan H. Gradman and A. Tareq Khawaja -- $g29.$tManaging Hypertension in Patients with Chronic Renal Insufficiency /$rCrystal A. Gadegbeku -- $g30.$tSupine Hypertension with Orthostatic Hypotension /$rGary L. Schwartz -- $g31.$tManagement of Renovascular Hypertension /$rMichael J. Bloch and Jan Basile -- $g32.$tManagement of Transplant Hypertension /$rC. Venkata S. Ram and Pedro Vergne-Marini -- $g33.$tManagement of Hypertensive Patients with Sexual Dysfunction /$rCarlos M. Ferrario -- $g34.$tNovel Cardiovascular Risk Factors and Their Use in Clinical Practice /$rPeter W. F. Wilson -- $gSect. VIII.$tUpdate on Hypertension and CVD Prevention in Special Populations -- $g35.$tHypertension in Pregnancy /$rSandra J. Taler -- $g36.$tPreventing Cardiovascular Disease in Women /$rAndrew P. Miller, Philippe Bouchard and Suzanne Oparil -- $g37.$tHypertension in African Americans /$rElijah Saunders, Wallace Johnson and Charlotte Jones-Burton -- $g38.$tHypertension in Adolescents /$rBonita Falkner -- $g39.$tHypertension in Surgical Patients /$rRanda K. Noseir and Thomas J. Ebert -- $gSect. IX.$tPharmacotherapeutic Considerations: Maximizing Opportunities and Minimizing Threats -- $g40.$tUse of Nonsteroidal Anti-inflammatory Drugs in Hypertensive Patients /$rPerry V. Halushka -- $g41.$tAmiloride-sensitive Hypertension /$rDavid A. Calhoun -- $g42.$tAdverse Drug Reactions in Patients with Hypertension /$rDomenic A. Sica.
650 0 $aHypertension.$0http://id.loc.gov/authorities/subjects/sh85063723
650 0 $aBlood circulation disorders.$0http://id.loc.gov/authorities/subjects/sh85014935
650 0 $aRenal hypertension.$0http://id.loc.gov/authorities/subjects/sh85112813
650 12 $aHypertension.$0https://id.nlm.nih.gov/mesh/D006973
650 12 $aBlood Circulation.$0https://id.nlm.nih.gov/mesh/D001775
650 12 $aHypertension, Renal.$0https://id.nlm.nih.gov/mesh/D006977
700 1 $aBasile, Jan N.$0http://id.loc.gov/authorities/names/n2003130595
700 1 $aLackland, Daniel T.$0http://id.loc.gov/authorities/names/n2003130597
830 0 $aHot topics.
852 00 $boff,hsl$hRC685.H8$iE436 2004